TechTalk Hemolysis
TechTalk Hemolysis
What Is Hemolysis?
Hemolysis is the breakage of the red blood cells (RBCs) membrane, causing the release of the hemoglobin and other
internal components into the surrounding fluid. Hemolysis is visually detected by showing a pink to red tinge in serum
or plasma.1 Hemolysis is a common occurrence seen in serum samples and may compromise the laboratorys test
parameters. Hemolysis can occur from two sources:
I n-vivo hemolysis may be due to pathological conditions, such as autoimmune hemolytic anemia or
transfusion reaction.1
In-vitro hemolysis may be due to improper specimen collection, specimen processing, or specimen transport.
Corrective Actions
Redraw the specimen.
T
he most common sites to draw from are the median cubital, basilic, and cephalic veins from the antecubital
region of the arm.
T
he choice of the needle gauge size is dependent on the patients physical characteristics and the amount of
blood to be drawn. Avoid using a needle that is too small or too large.
The tourniquet should be released after no more than one minute, and excessive fist clenching should be avoided.
Without touching, allow the venipuncture site to air dry.
Avoid drawing the syringe plunger back too forcefully when collecting blood with a needle and syringe.
A
void pushing the plunger too forcefully when transferring to a tube. Use a blood transfer device when transferring
from a syringe to a tube without pushing the plunger.
E
nsure all blood collection assemblies are fitted securely, to avoid frothing. Utilize a luer-locking device with
infusion equipment to ensure a secure fit.14
G
ently invert the blood collection tube and mix additive specimens thoroughly according to manufacturers
recommendations.
- I nvert specimen with a clot activator 5 times to ensure the distribution of the clot activator within the sample,
and allow the specimen to clot for a full 30 minutes in a vertical position.
- Non-gel serum tubes should be allowed to clot for 60 minutes in a vertical position.
- Sodium citrate tubes for coagulation testing should be inverted 3-4 times.
- All other anticoagulant tubes should be inverted 8-10 times.3
References:
1. Lemery L. Oh, No! Its Hemolyzed! What, Why, Who, How? Advance for Medical Laboratory Professionals, Feb. 15, 1998: 24-25.
2. Burns ER, Yoshikawa N. Hemolysis in serum samples drawn by emergency department personnel versus laboratory phlebotomists.
Lab Med. 2002; 33: 378 380.
3. CLSI Document H3-A6. Procedures for the collection of diagnostic blood specimens by venipuncture; approved standard 6th ed.
Wayne, PA: National Committee for Clinical Laboratory Standards; 1998.
4. Garza D and Becan-McBride K. Phlebotomy Handbook, 5th Ed. Stamford, CT: Appleton & Lange; 1999.
5. Laessig RH, Hassemer DJ, Paskey TA., Schwartz TH, The effects of 0.1 % and 1.0 % erythrocytes and hemolysis on serum chemistry values.
Am J Clin. Pathol. 1976; 66: 639-44.
6. Sharp MK, Mohammad SF. Scaling of hemolysis in needles and catheters. Ann Biochem Engineer. 1998; 26: 788-797.
7. Savory J. Bill JG. Hemolysis of specimens drawn in the ER [Q&A]. Lab Med. 1996; 27: 802.
8. Kennedy C, Angemuller S, King R, et al. A comparison of hemolysis rates using intravenous catheters versus venipuncture tubes for obtaining
blood samples. J Emer Nurs 1996; 22: 566-9.
9. Boyanton BL. Jr. Blick KE., Stability studies of twenty-four analytes in human plasma and serum. Clin. Chem. 2002; 48: 2242-7.
10. Kroll MH, Elin RJ. Interference with clinical laboratory analyses (review). Clin. Chem. 1994; 40: 1996-2005.
11. Sonntag O. Haemolysis as an interference factor in clinical chemistry. J Clin Chem Clin Biochem. 1986; 24: 127-39.
12. Frank JJ, Bermes EW, Bickel MJ, Watkins BF. Effect of in vitro hemolysis on chemical values for serum. Clin Chem. 1978; 24: 1966-70.
13. Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem. 2000; 46: 306-7.
14. Journal of Infusion Nursing, Infusion Nursing Standards of Practice, Jan/Feb 2006; Vol. 29, No. 1S.